CC BY-NC-ND 4.0 · AJP Rep 2018; 08(04): e261-e263
DOI: 10.1055/s-0038-1675376
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Recurrent Cholangiocarcinoma in Pregnancy: A Case Report

Antonia P. Francis
1   Department of Obstetrics and Gynecology, New York University Langone Health, New York, New York
,
Michelle Chang
2   Department of Medicine, Columbia University Irving Medical Center, New York, New York
,
Cara D. Dolin
4   Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia
,
Judith Chervenak
1   Department of Obstetrics and Gynecology, New York University Langone Health, New York, New York
,
Elyce Cardonick
3   Department of Obstetrics and Gynecology, Cooper University Health Care, Camden, New Jersey
› Author Affiliations
Further Information

Publication History

22 February 2018

05 September 2018

Publication Date:
12 November 2018 (online)

Abstract

Hepatobiliary malignancies during pregnancy are extremely rare and portend a poor prognosis. There are only seven published cases of cholangiocarcinoma in an obstetrical patient, all are cases of primary cholangiocarcinoma (1–7). Herein, we describe the first case of recurrent cholangiocarcinoma during pregnancy. The patient did not receive chemotherapy during pregnancy and required prolonged hospitalizations for nutritional and intensive medical support. She delivered preterm, at 30 2/7 weeks gestation, after developing pre-eclampsia with severe features. The infant was healthy, with no malformations, and currently exhibits no neurological or behavioral sequelae at 8months of age. We discuss themanagement considerations inherent to this complex clinical scenario including metastatic disease severity, ethical considerations, and palliative care treatment options.

 
  • References

  • 1 Gerli S, Favilli A, Giordano C, Donini A, Di Renzo GC. Mixed hepatocellular carcinoma and cholangiocarcinoma during pregnancy: a case report. Eur J Obstet Gynecol Reprod Biol 2015; 187: 76-77
  • 2 Sadoon S, Hodgett S. Unusual cause of itching in a pregnancy (cholangiocarcinoma). J Obstet Gynaecol 2008; 28 (02) 230-231
  • 3 Stone S, Girling JC. Deranged liver function tests in pregnancy: the importance of postnatal follow-up. Obstet Med 2009; 2 (01) 32-33
  • 4 Marasinghe JP, Karunananda SA, Angulo P. Cholangiocarcinoma in pregnancy: a case report. J Obstet Gynaecol Res 2008; 34 (4, Pt 2): 635-637
  • 5 Balderston KD, Tewari K, Azizi F, Yu JK. Intrahepatic cholangiocarcinoma masquerading as the HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) in pregnancy: case report. Am J Obstet Gynecol 1998; 179 (3, Pt 1): 823-824
  • 6 Devoe LD, Moossa AR, Levin B. Pregnancy complicated by extrahepatic biliary tract carcinoma. A case report. J Reprod Med 1983; 28 (02) 153-155
  • 7 Purtilo DT, Clark JV, Williams R. Primary hepatic malignancy in pregnant women. Am J Obstet Gynecol 1975; 121 (01) 41-44
  • 8 Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120 (04) c179-c184
  • 9 Albright CM, Wenstrom KD. Malignancies in pregnancy. Best Pract Res Clin Obstet Gynaecol 2016; 33: 2-18
  • 10 Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol 2003; 189 (04) 1128-1135
  • 11 Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist 2002; 7 (04) 279-287
  • 12 Doherty B, Nambudiri VE, Palmer WC. Update on the diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep 2017; 19 (01) 2
  • 13 Cunningham SC, Choti MA, Bellavance EC, Pawlik TM. Palliation of hepatic tumors. Surg Oncol 2007; 16 (04) 277-291
  • 14 Blechacz B. Cholangiocarcinoma: current knowledge and new developments. Gut Liver 2017; 11 (01) 13-26
  • 15 Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011; 54 (01) 173-184